Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-53,366
Closed -$524K 2754
2025
Q2
$524K Buy
+53,366
New +$442K 0.02% 1067
2024
Q3
Sell
-31,978
Closed -$256K 2227
2024
Q2
$256K Buy
+31,978
New +$286K 0.02% 1064
2023
Q4
Sell
-14,532
Closed -$224K 1735
2023
Q3
$224K Buy
+14,532
New +$244K 0.04% 954
2022
Q4
Sell
-30,648
Closed -$177K 1238
2022
Q3
$177K Buy
+30,648
New +$135K 0.04% 823
2022
Q2
Sell
-47,147
Closed -$178K 925
2022
Q1
$178K Buy
+47,147
New +$304K 0.08% 433

Other funds holding ETNB

XTX Topco's ETNB Position: Q3 2025 in Review

XTX Topco sold out of 89bio (ETNB) in Q3 2025, closing a stake of 53,366 shares — an estimated $524K sold.

XTX Topco first reported a position in ETNB in Q1 2022 and held it in 5 quarters. The position peaked at $524K in Q2 2025. 198 funds tracked by Wall St. Rank hold ETNB as of Q3 2025.

  • XTX Topco reported no remaining 89bio position as of Q3 2025 after selling out during the quarter.
  • XTX Topco sold 53,366 89bio shares in Q3 2025, an estimated $524K.
  • XTX Topco first reported a position in 89bio in Q1 2022 and held it in 5 quarters.
  • XTX Topco's 89bio position peaked at $524K in Q2 2025.
  • 198 funds tracked by Wall St. Rank held 89bio as of Q3 2025.

Based on XTX Topco's 13F filing for Q3 2025, filed 14 Nov 2025.